In this conversation, Davis Corley from Neurolens discusses the HIT6 study and the impact of Neurolens on headache management. The conversation addresses the criticism of the study and the importance of skepticism in optometry. The chapters cover topics such as the choice of HIT6 as a measurement tool, the severity and impact of HIT6 scores, the cost effectiveness of Neurolens compared to other treatments, and the safety profile of Neurolens. The conversation also explores the expansion of Neurolens' research, the perception of price and value, and the position of Neurolens in the market and insurance coverage. The conversation concludes with a discussion on the clinical significance and meaningful outcomes of Neurolens and the importance of evidence-based medicine and continued innovation. HA Studies: https://pubmed.ncbi.nlm.nih.gov/28460892/ https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6513576/ https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10833052/ https://pubmed.ncbi.nlm.nih.gov/18047501/ VS Exchange - https://docs.google.com/forms/d/e/1FAIpQLSfW9C2sOgXZxVFT2jd3t3037ZX02RH3zl-iXKERaoZTtd6i7A/viewform -------------------------------- For our listeners, use the code 'EYECODEMEDIA22' for 10% off at check out for our Premiere Billing & Coding bundle or our EyeCode Billing & Coding course. Sharpen your billing and coding skills today and leave no money on the table! Show Sponsors: CooperVision MacuHealth EssilorLuxottica